| 中文名 | 达沙替尼羧酸乙酯 |
|---|---|
| 英文名 | ethyl 2-[4-[6-[[5-[(2-chloro-6-methylphenyl)carbamoyl]-1,3-thiazol-2-yl]amino]-2-methylpyrimidin-4-yl]piperazin-1-yl]acetate |
| 英文别名 |
4-[6-[[5-[[(2-Chloro-6-methylphenyl)amino]carbonyl]-2-thiazolyl]amino]-2-methyl-4-pyrimidinyl]-1-piperazineacetic Acid Ethyl Ester
ethyl 2-(4-(6-(5-((2-chloro-6-methylphenyl)carbamoyl)thiazol-2-ylamino)-2-methylpyrimidin-4-yl)piperazin-1-yl)acetate Dasatinib Carboxylic Acid Ethyl Ester Dasatinib Impurity 2 |
| 分子式 | C24H28ClN7O3S |
|---|---|
| 分子量 | 530.04200 |
| 精确质量 | 529.16600 |
| PSA | 144.31000 |
| LogP | 4.34420 |
|
~89%
910297-62-0 |
| 文献：CURIS, INC. Patent: WO2008/33746 A2, 2008 ; Location in patent: Page/Page column 58 ; WO 2008/033746 A2 |
|
~89%
910297-62-0 |
| 文献：Bristol-Myers Squibb Company Patent: US2007/219370 A1, 2007 ; Location in patent: Page/Page column 29 ; |
